Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FL002
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $150,882
Award facts
- Contract value 100% obligated
- $150,882.31 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $150,882.31 to AmerisourceBergen Drug Corp on October 20, 2025, under the Pharmaceutical PV Division contract. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is set for completion by October 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which functions as a global pharmaceutical support vehicle enabling the company to supply comprehensive pharmaceutical products and medical supplies to military healthcare programs worldwide.
This delivery order is part of the broader DLA pharmaceutical supply chain supporting defense health operations. AmerisourceBergen's IDC encompasses a wide range of critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and medical test kits across multiple therapeutic domains. The company's capabilities demonstrate versatility in fulfilling federal medical supply needs across varying order values and product categories. As the DLA develops the Pharmaceutical Prime Vendor Global Program Generation V contracts with plans for multiple regional awards involving separate contractors, AmerisourceBergen continues to serve key customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Quick answers
Who was awarded contract SPE2DU26FL002?
SPE2DU26FL002 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DU26FL002 worth?
The government has obligated $150,882 on SPE2DU26FL002.
Is contract SPE2DU26FL002 an order under another contract?
Yes. SPE2DU26FL002 is a delivery order under SPE2DU25D4118, an indefinite delivery contract.
Was contract SPE2DU26FL002 competed?
The extent of competition for SPE2DU26FL002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award